Recombinant Human Erythropoietin Alfa is an erythropoiesis-stimulating agent (ESA) produced by recombinant DNA technology in cell culture. It is used in the treatment of following conditions:
Anaemia caused due to chronic kidney disease, chemotherapy in cancer patients, Crohn’s disease, ulcerative colitis (long-term condition of ulcer and inflammation), irritable bowel syndrome (inflammatory conditions of colon (IBS)) and myelodysplasia (type of cancer where immature cells don’t mature in bone marrow)
Some common side effects that may be caused by the administration of Recombinant Human Erythropoietin Alfa are:
Please consult a physician if the symptoms are persistent.
Please inform your doctor if you have any of the following conditions:
Recombinant Human Erythropoietin Alfa is an erythropoiesis-stimulating agent (ESA) produced by recombinant DNA technology in cell culture. It is used in the treatment of following conditions:
Anaemia caused due to chronic kidney disease, chemotherapy in cancer patients, Crohn’s disease, ulcerative colitis (long-term condition of ulcer and inflammation), irritable bowel syndrome (inflammatory conditions of colon (IBS)) and myelodysplasia (type of cancer where immature cells don’t mature in bone marrow)
Some common side effects that may be caused by the administration of Recombinant Human Erythropoietin Alfa are:
Please consult a physician if the symptoms are persistent.
Please inform your doctor if you have any of the following conditions: